<DOC>
	<DOCNO>NCT00701948</DOCNO>
	<brief_summary>This study aim evaluate new dosage inflammatory marker new inflammatory marker diagnosis nosocomial bacterial infection . We make hypothesis new dosage new inflammatory marker could useful dosage inflammatory marker already use clinical practice ( especially use combination interleukin ( 6 8 ) C-reactive protein management newborns clinical suspicion nosocomial bacterial infection especially could allow avoid excessive treatment antibiotic</brief_summary>
	<brief_title>New Dosages Inflammatory Markers Early Diagnosis Nosocomial Bacterial Infections Newborn</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Cross Infection</mesh_term>
	<criteria>Newborns &gt; 72 hour life hospitalize neonatal intensive intermediate care unit present clinical suspicion NBI Early postoperative period ( surgery le 48 hour ) Multiple malformation Newborn already include study previous septic event Newborn treat antibiotic last 24 hour</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>90 Days</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Late onset neonatal sepsis</keyword>
	<keyword>Nosocomial bacterial infection</keyword>
	<keyword>Inflammatory marker</keyword>
	<keyword>multiplex dosage</keyword>
</DOC>